20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LEVETIRACETAM, with a corresponding US DMF Number 16894.
Remarkably, this DMF maintains an Active status since its submission on October 05, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 26, 2012, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II